The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM - PubMed (original) (raw)

Editorial

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM

Stephen B Edge et al. Ann Surg Oncol. 2010 Jun.

Abstract

The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

PubMed Disclaimer

Comment in

• TNM: it is time to consider further expanding both the M stage as well as the R stage.
  Shukla PJ, Milsom JW. Shukla PJ, et al. Ann Surg Oncol. 2011 Dec;18 Suppl 3:S297-9; author reply S300. doi: 10.1245/s10434-010-1345-0. Epub 2010 Oct 14. Ann Surg Oncol. 2011. PMID: 20945106 No abstract available.
• Pathologic fracture in osteosarcoma: Association with poorer overall survival.
  Salunke AA, Shah J, Gupta N, Pandit J. Salunke AA, et al. Eur J Surg Oncol. 2016 Jun;42(6):889-90. doi: 10.1016/j.ejso.2016.02.255. Epub 2016 Mar 14. Eur J Surg Oncol. 2016. PMID: 27012998 No abstract available.

Similar articles

• Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
  Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform. Gershenwald JE, et al. CA Cancer J Clin. 2017 Nov;67(6):472-492. doi: 10.3322/caac.21409. Epub 2017 Oct 13. CA Cancer J Clin. 2017. PMID: 29028110 Free PMC article.
• The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer.
  Olawaiye AB, Baker TP, Washington MK, Mutch DG. Olawaiye AB, et al. CA Cancer J Clin. 2021 Jul;71(4):287-298. doi: 10.3322/caac.21663. Epub 2021 Mar 30. CA Cancer J Clin. 2021. PMID: 33784415
• The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
  Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. Amin MB, et al. CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17. CA Cancer J Clin. 2017. PMID: 28094848
• Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
  Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Paner GP, et al. Eur Urol. 2018 Apr;73(4):560-569. doi: 10.1016/j.eururo.2017.12.018. Epub 2018 Jan 9. Eur Urol. 2018. PMID: 29325693 Review.
• Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual.
  Ford J, Thakar S, Thuro B, Esmaeli B. Ford J, et al. Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):317-324. doi: 10.1097/IOP.0000000000000901. Ophthalmic Plast Reconstr Surg. 2017. PMID: 28350693 Review.

Cited by

• Clinical Features and Prognosis of Primary Epithelial-Myoepithelial Carcinoma of Salivary Gland: A Surveillance, Epidemiology, and End Results Database-Based Study.
  Han H, Pan LN. Han H, et al. Cancer Control. 2024 Jan-Dec;31:10732748241288419. doi: 10.1177/10732748241288419. Cancer Control. 2024. PMID: 39495650 Free PMC article.
• Clinicopathological significance of claudin-4 in gastric carcinoma.
  Zhu JL, Gao P, Wang ZN, Song YX, Li AL, Xu YY, Wang MX, Xu HM. Zhu JL, et al. World J Surg Oncol. 2013 Jul 4;11:150. doi: 10.1186/1477-7819-11-150. World J Surg Oncol. 2013. PMID: 23822740 Free PMC article.
• NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients.
  Liu L, Xu Q, Cheng L, Ma C, Xiao L, Xu D, Gao Y, Wang J, Song H. Liu L, et al. Oncol Lett. 2015 Feb;9(2):891-896. doi: 10.3892/ol.2014.2721. Epub 2014 Nov 20. Oncol Lett. 2015. PMID: 25624911 Free PMC article.
• Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
  Yin F, Wang S, Hou C, Zhang Y, Yang Z, Wang X. Yin F, et al. Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022. Front Public Health. 2022. PMID: 36203704 Free PMC article.
• Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
  Rosignolo F, Maggisano V, Sponziello M, Celano M, Di Gioia CR, D'Agostino M, Giacomelli L, Verrienti A, Dima M, Pecce V, Durante C. Rosignolo F, et al. J Endocrinol Invest. 2015 Dec;38(12):1283-9. doi: 10.1007/s40618-015-0309-4. Epub 2015 May 24. J Endocrinol Invest. 2015. PMID: 26003825

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database